LEARN MORE ABOUT US

Here’s Our Story

2017

IRUBIS GmbH is founded and wins the Medical Valley Award. The team develops a silicon crystal for infrared spectroscopy.

2018

Technological proof of concept: Online monitoring of glucose with IRUBIS silicon crystal and a mid-infrared spectrometer.

2019

Our prototype is tested at biopharma companies.

2020

IRUBIS is one of the winners of the H2020 EIC Accelerator Pilot and uses this momentum and grant to develop Monipa and to validate prototype in the biopharma industry.

2021

Market entry with Monipa: Online monitoring in upstream bioprocessing of metabolite and nutrient concentration and for automated glucose control.

2022

IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene.

2023

Released the new Monipa 1 with a modern and user-friendly design, delved into downstream applications, enhancing both innovation and functionality in the bioprocessing industry.

2024

IRUBIS has successfully closed the pre-series A funding round, led by BioProcess360 Partners, with support from our valued investors, including High-Tech Gründerfonds, Verve Ventures, Ventura BioMed Investors, RoBet KG, and esteemed business angels Matthias Arnold and Dr. Christoph Bremus. Expanded applications of the new Monipa 1 in UF/DF and other downstream processing steps.